Axel W Einarsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Axel W Einarsson has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Agnar Helgason
1] deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. [2] Department of Anthropology, University of Iceland, Reykjavik, Iceland
1 shared publication- Anuradha Jagadeesan
DeCODE Genetics/AMGEN, Reykjavik 101, Iceland
1 shared publication - Augustine Kong
Leverhulme Centre for Demographic Science, Nuffield Department of Population Health, University of Oxford and Nuffield College, Oxford, UK
1 shared publication Ellen D Gunnarsdóttir
DeCODE Genetics/Amgen, Inc., Reykjavik, Iceland
1 shared publicationKári Stefánsson
1] deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. [2] Faculty of Medicine, University of Iceland, Reykjavík, Iceland
1 shared publicationS Sunna Ebenesersdóttir
1] deCODE Genetics/Amgen, Inc., Reykjavik, Iceland. [2] Department of Anthropology, University of Iceland, Reykjavik, Iceland
1 shared publication
Latest Publications
- 25 March 2015
- Published by Springer Nature in Nature Genetics
- Vol. 47 (5) , 453-457
The Y-chromosome point mutation rate in humans
Agnar Helgason and colleagues report the point mutation rate for the male-specific euchromatic sequence of the Y chromosome based on 753 Icelandic males. They find that the non-recombining portions of the Y chromosome mutate at a faster rate than palindromic regions, suggesting that gene conversion acts to correct mutations in palindromic sequences.
- 25 March 2015
- Published by Springer Nature in Nature Genetics
- Vol. 47 (5) , 453-457
The Y-chromosome point mutation rate in humans
Agnar Helgason and colleagues report the point mutation rate for the male-specific euchromatic sequence of the Y chromosome based on 753 Icelandic males. They find that the non-recombining portions of the Y chromosome mutate at a faster rate than palindromic regions, suggesting that gene conversion acts to correct mutations in palindromic sequences.